(Q51713351)

English

Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis.

scientific article published on 21 September 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

liver cirrhosis

0 references

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

author name string

Prakash Baligar

1

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

Snehasish Mukherjee

2

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

Veena Kochat

3

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

Archana Rastogi

4

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

Asok Mukhopadhyay

5

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

publication date

21 September 2015

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

34

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

1

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

135-147

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Therapeutic targeting of the PDGF and TGF-beta-signaling pathways in hepatic stellate cells by PTK787/ZK22258

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Evolving therapies for liver fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Adipose tissue-derived stem cells as a regenerative therapy for a mouse steatohepatitis-induced cirrhosis model.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Macrophage heterogeneity in liver injury and fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Modulation of monocyte/macrophage function: a therapeutic strategy in the treatment of acute liver failure.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

The bone marrow functionally contributes to liver fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Bone marrow stem-cell therapy for genetic and chronic liver diseases.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Extracellular matrix degradation and the role of hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Proteinases involved in matrix turnover during cartilage and bone breakdown.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Identification of retinal ganglion cell neuroprotection conferred by platelet-derived growth factor through analysis of the mesenchymal stem cell secretome

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Cytokine interactions in mesenchymal stem cells from cord blood

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Amelioration of hepatic fibrosis by NK cell activation.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Hematopoietic stem cells convert into liver cells within days without fusion

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Characterization of the potential subpopulation of bone marrow cells involved in the repair of injured liver tissue.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

The therapeutic effect of bone marrow-derived liver cells in the phenotypic correction of murine hemophilia A.

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Transplanted bone marrow regenerates liver by cell fusion

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Cell fusion is the principal source of bone-marrow-derived hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Ploidy reductions in murine fusion-derived hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.2210

21 January 2018

Identifiers

10.1002/STEM.2210

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/26389810

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51713351&oldid=2157819710"